MODULATION OF TYROSINE KINASE SIGNALING PATHWAYS IN HUMAN BREAST-CANCER CELLS

被引：0
|
作者：
DALY, RJ [1 ]
BINDER, MD [1 ]
JANES, PW [1 ]
SUTHERLAND, RL [1 ]
机构：
[1] ST VINCENTS HOSP,GARVAN INST MED RES,DIV CANC BIOL,SYDNEY,NSW 2010,AUSTRALIA
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1994年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：237 / 237
页数：1
相关论文
共 50 条
  • [41] INHIBITORY EFFECT OF MEVALONATE ON THE EGF MITOGENIC SIGNALING PATHWAY IN HUMAN BREAST-CANCER CELLS IN CULTURE
    LARSSON, O
    BLEGEN, H
    CANCER BIOCHEMISTRY BIOPHYSICS, 1994, 14 (03): : 193 - 200
  • [42] ACTIVATION OF THE RAS SIGNALING PATHWAY IN HUMAN BREAST-CANCER CELLS OVEREXPRESSING ERBB-2
    JANES, PW
    DALY, RJ
    DEFAZIO, A
    SUTHERLAND, RL
    ONCOGENE, 1994, 9 (12) : 3601 - 3608
  • [43] INVOLVEMENT OF PP60(C-SRC) WITH 2 MAJOR SIGNALING PATHWAYS IN HUMAN BREAST-CANCER
    LUTTRELL, DK
    LEE, A
    LANSING, TJ
    CROSBY, RM
    JUNG, KD
    WILLARD, D
    LUTHER, M
    RODRIGUEZ, M
    BERMAN, J
    GILMER, TM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) : 83 - 87
  • [44] Impact of tyrosine kinase expression levels in human breast cancer cells on their response to treatment with combinations of small-molecule tyrosine kinase inhibitors
    Stanley, Aryan
    Modjtajhedi, Helmout
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 194 - 194
  • [45] ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer
    Hinohara, Kunihiko
    Kobayashi, Seiichiro
    Kanauchi, Hajime
    Shimizu, Seiichiro
    Nishioka, Kotoe
    Tsuji, Ei-ichi
    Tada, Kei-ichiro
    Umezawa, Kazuo
    Mori, Masaki
    Ogawa, Toshihisa
    Inoue, Jun-ichiro
    Tojo, Arinobu
    Gotoh, Noriko
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (17) : 6584 - 6589
  • [46] MAPK signaling is involved in intrinsic and acquired resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
    Normanno, N.
    Maiello, M. R.
    De Luca, A.
    Carotenuto, A.
    Rachiglio, A. M.
    D'Alessio, A.
    ANNALS OF ONCOLOGY, 2006, 17 : VII146 - VII146
  • [47] Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response
    Ursini-Siegel, Josie
    Cory, Sean
    Zuo, Dongmei
    Hardy, William R.
    Rexhepaj, Elton
    Lam, Sonya
    Schade, Babette
    Jirstrom, Karin
    Bjur, Eva
    Piccirillo, Ciriaco A.
    DeNardo, David
    Coussens, Lisa M.
    Brennan, Donal J.
    Gallagher, William M.
    Park, Morag
    Pawson, Tony
    Hallett, Michael
    Muller, William J.
    CANCER RESEARCH, 2010, 70 (20) : 7776 - 7787
  • [48] ANGIOGENESIS BY HUMAN-MELANOMA AND BREAST-CANCER CELLS
    CHAUDHURY, TK
    LERNER, MP
    NORDQUIST, RE
    CANCER LETTERS, 1980, 11 (01) : 43 - 49
  • [49] PROLACTIN SYNTHESIS AND SECRETION BY HUMAN BREAST-CANCER CELLS
    GINSBURG, E
    VONDERHAAR, BK
    CANCER RESEARCH, 1995, 55 (12) : 2591 - 2595
  • [50] HER-3 TYROSINE KINASE PATHWAY TARGETS ESTROGEN-RECEPTOR AND PROMOTES HORMONE-INDEPENDENT GROWTH IN HUMAN BREAST-CANCER CELLS
    PIETRAS, RJ
    ARBOLEDA, J
    REESE, DM
    WONGVIPAT, N
    PEGRAM, MD
    RAMOS, L
    GORMAN, CM
    PARKER, MG
    SLIWKOWSKI, MX
    SLAMON, DJ
    ONCOGENE, 1995, 10 (12) : 2435 - 2446
12345